Results 141 to 150 of about 268,538 (298)

Is it time to repair a fairly fast SAAB convertible? Testing an evidence-based mnemonic for the secondary prevention of cardiovascular disease [PDF]

, 2014
OBJECTIVES: Optimising secondary prevention of cardiovascular disease has the greatest potential to reduce recurrent events, yet despite major guidelines there are ongoing treatment gaps.
Chin, Jialiang, Fulcher, Jordan, Jenkins, Alicia, Keech, Anthony   +3 more
core  

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. [PDF]

, 1981
D. B. Brunner, G Desponds, Jérôme Biollaz, I Keller, F Ferber, Haralambos Gavras, Brunner Hr, JL Schelling   +7 more
openalex   +1 more source

Machine Learning Approaches to Investigate the Structure-Activity Relationship of Angiotensin-Converting Enzyme Inhibitors. [PDF]

ACS Omega, 2023
Yu T, Nantasenamat C, Anuwongcharoen N, Piacham T.   +3 more
europepmc   +1 more source

The effect of an angiotensin converting enzyme inhibitor, ramipril, on bronchial responses to inhaled histamine and bradykinin in asthmatic subjects. [PDF]

, 1987
CM Dixon, RW Fuller, Peter J. Barnes
openalex   +1 more source

Response and survival of dogs with proteinuria (UPC > 2.0) treated with angiotensin converting enzyme inhibitors. [PDF]

J Vet Intern Med, 2023
Fulton EA, McBrearty AR, Shaw DJ, Ridyard AE.   +3 more
europepmc   +1 more source

Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man. [PDF]

, 1987
KR Lees, JL Reid
openalex   +1 more source

Pharmacogenomic knowledge and awareness among diverse patients treated with angiotensin converting enzyme inhibitors. [PDF]

Pharmacogenomics, 2023
Naik H, O'Connor MY, Sanderson SC, Pinnell N, Dong M, Wiegand A, Obeng AO, Abul-Husn NS, Scott SA.   +8 more
europepmc   +1 more source

POTENTIATION OF THE ALGOGENIC ACTION OF BRADYKININ BY AN INHIBITOR OF ANGIOTENSIN I CONVERTING ENZYME, CAPTOPR1L (SQ 14,225)

, 1979
Takasuke Nakano, Norio Taira
openalex   +1 more source

Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril). [PDF]

, 1984
F. M. Fouad, Robert C. Tarazi, E L Bravo, Stephen C. Textor   +3 more
openalex   +1 more source

Integration of Genetic Algorithms and Deep Learning for the Generation and Bioactivity Prediction of Novel Tyrosine Kinase Inhibitors [PDF]

arXiv
The intersection of artificial intelligence and bioinformatics has enabled significant advancements in drug discovery, particularly through the application of machine learning models. In this study, we present a combined approach using genetic algorithms and deep learning models to address two critical aspects of drug discovery: the generation of novel
arxiv